Admission Date:  [**2148-5-7**]       Discharge Date:  [**2148-5-13**]  Date of Birth:   [**2097-9-27**]       Sex:  M  Service:  TRANS [**Doctor First Name 147**]  HISTORY OF PRESENT ILLNESS:   The patient is a 50 year old male status post orthotopic liver transplantation on [**2148-3-5**], for end stage liver disease secondary to hepatitis C cirrhosis.
The patient's post transplantation course was complicated by reactivation of hepatitis C and persistently elevated liver function tests and bilirubin for which the patient was recently hospitalized in the month of [**2148-4-1**].
The patient underwent an endoscopic retrograde cholangiopancreatography on [**2148-4-4**], at which time he had a spincterotomy done and a stent placed.
The patient also had left upper extremity deep vein thrombosis for which he was placed on Coumadin and was being followed as an outpatient.
Cirrhosis status post orthotopic liver transplant on [**2148-3-5**] complicated by reactivation of hepatitis C and biliary stricture status post endoscopic retrograde cholangiopancreatography with sphincterotomy and stent; status post endoscopic retrograde cholangiopancreatography and removal of biliary stent.
Bactrim Single Strength one tablet p.o.
Valcyte 450 mg p.o.
Protonix 40 mg p.o.
Lopressor 25 mg p.o.
Isordil 30 mg p.o.
Neoral 75 mg p.o.
Reglan 5 mg three times a day.
Actigall 300 mg p.o.
Fluconazole 200 mg p.o.
Hydralazine 30 mg p.o.
Prednisone 50 mg p.o.
Humalog 75/25 mixed, 15 units subcutaneously q. a.m. and 4 units subcutaneously q. p.m. 15.
Peg-intron 180 micrograms subcutaneously q. weekly.
Ribavirin 200 mg p.o.
Coumadin 2 mg p.o.
PHYSICAL EXAMINATION:   On admission, afebrile with temperature 98.8 F.; heart rate of 84; blood pressure 141/92; respiratory rate of 20; 99% on room air.
HOSPITAL COURSE:   The patient was admitted for observation because of his elevated INR and obviously decreased hematocrit.
The patient received two units of fresh frozen plasma with reduction in INR from 3.5 to 1.7 in the morning of hospital day two.
The patient received two additional units of fresh frozen plasma and one unit of platelets giving a platelet count of 54.
The patient continued on his immunosuppressive therapy starting on hospital day one, taking Neoral 75 mg p.o.
four times a day and Prednisone 15 mg.
The Neoral dose was adjusted as per his morning C2 level, however, these levels tended to fluctuate despite the patient receiving the medication on time.
The patient's liver function tests did not significant improve with alkaline phosphatase staying at 1035 and after discussion with Transplant Hepatology, the patient was given a single dose of a short acting Interferon Alpha 2B, three million units subcutaneously times one.
Hepatitis C cirrhosis status post orthotopic liver transplant.
History of deep vein thrombosis on Coumadin with elevated INR and liver function tests.
Neoral 125 mg p.o.
Prednisone 50 mg p.o.
Bactrim Single Strength one tablet p.o.
Valcyte 450 mg p.o.
Protonix 40 mg p.o.
Lopressor 25 mg p.o.
Reglan 5 mg p.o.
Actigall 300 mg p.o.
Fluconazole 200 mg p.o.
Hydralazine 30 mg p.o.
Isosorbide 30 mg p.o.
Humalog 75/25, 15 units subcutaneously q. a.m. and 4 units subcutaneously q. p.m. 14.
